Open AccessA RETROSPECTIVE ANALYSIS OF EFFICACY OF HEMOADSORPTION (CYTOSORB®) IN REFRACTORY SEPTIC SHOCK PATIENTS AS AN ADJUVANT
Author(s) -
M Surendra,
Bharath Cherukuri,
Sai Kumar,
Nagasri Haritha,
Lakshmi Kantham,
Silpa Silpa,
Bhavya Bhavya,
Srikanth Srikanth,
Jyothi Jyothi
Publication year - 2019
Publication title -
international journal of scientific research
Language(s) - English
DOI - 10.36106/8400805
Subject(s) - medicine , septic shock , refractory (planetary science) , sepsis , adjuvant , adjuvant therapy , shock (circulatory) , intensive care medicine , surgery , chemotherapy , physics , astrobiology
Dysregulated response of cytokines can result in hyper-inflammatory conditions called cytokine storm,commonly seen in sepsis and septicshock..The current study assessed hemoadsorption device - CytoSorb® for its efficiency as an adjuvant in treating patients suffering from septicshock. Total 8 patients enrolled were subjected to hemoadsorption therapy along with the standard treatment.The results of the study revealedsignificant improvement in clinical and haemodynamic parameters before and after initiation of CytoSorb® therapy. Out of 8 patients, 6 showed apositive outcome while 2 did not survive.The results of this study show that the use of hemoadsorption therapy can be considered in critically illICU patients as a safe and effective adjuvant therapy along with the standard treatment for a better outcome in patients.